Fig. 2From: Inconsistent approaches of the G-BA regarding acceptance of primary study endpoints as being relevant to patients - an analysis of three disease areas: oncological, metabolic, and infectious diseasesAdaptable and disease-specific weighting of endpoint categoriesBack to article page